Literature DB >> 26287746

FTO Obesity Variant Circuitry and Adipocyte Browning in Humans.

Melina Claussnitzer1, Simon N Dankel, Kyoung-Han Kim, Gerald Quon, Wouter Meuleman, Christine Haugen, Viktoria Glunk, Isabel S Sousa, Jacqueline L Beaudry, Vijitha Puviindran, Nezar A Abdennur, Jannel Liu, Per-Arne Svensson, Yi-Hsiang Hsu, Daniel J Drucker, Gunnar Mellgren, Chi-Chung Hui, Hans Hauner, Manolis Kellis.   

Abstract

BACKGROUND: Genomewide association studies can be used to identify disease-relevant genomic regions, but interpretation of the data is challenging. The FTO region harbors the strongest genetic association with obesity, yet the mechanistic basis of this association remains elusive.
METHODS: We examined epigenomic data, allelic activity, motif conservation, regulator expression, and gene coexpression patterns, with the aim of dissecting the regulatory circuitry and mechanistic basis of the association between the FTO region and obesity. We validated our predictions with the use of directed perturbations in samples from patients and from mice and with endogenous CRISPR-Cas9 genome editing in samples from patients.
RESULTS: Our data indicate that the FTO allele associated with obesity represses mitochondrial thermogenesis in adipocyte precursor cells in a tissue-autonomous manner. The rs1421085 T-to-C single-nucleotide variant disrupts a conserved motif for the ARID5B repressor, which leads to derepression of a potent preadipocyte enhancer and a doubling of IRX3 and IRX5 expression during early adipocyte differentiation. This results in a cell-autonomous developmental shift from energy-dissipating beige (brite) adipocytes to energy-storing white adipocytes, with a reduction in mitochondrial thermogenesis by a factor of 5, as well as an increase in lipid storage. Inhibition of Irx3 in adipose tissue in mice reduced body weight and increased energy dissipation without a change in physical activity or appetite. Knockdown of IRX3 or IRX5 in primary adipocytes from participants with the risk allele restored thermogenesis, increasing it by a factor of 7, and overexpression of these genes had the opposite effect in adipocytes from nonrisk-allele carriers. Repair of the ARID5B motif by CRISPR-Cas9 editing of rs1421085 in primary adipocytes from a patient with the risk allele restored IRX3 and IRX5 repression, activated browning expression programs, and restored thermogenesis, increasing it by a factor of 7.
CONCLUSIONS: Our results point to a pathway for adipocyte thermogenesis regulation involving ARID5B, rs1421085, IRX3, and IRX5, which, when manipulated, had pronounced pro-obesity and anti-obesity effects. (Funded by the German Research Center for Environmental Health and others.).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26287746      PMCID: PMC4959911          DOI: 10.1056/NEJMoa1502214

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

1.  Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues.

Authors:  Jason Ernst; Manolis Kellis
Journal:  Nat Biotechnol       Date:  2015-02-18       Impact factor: 54.908

2.  Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3.

Authors:  Anja Ragvin; Enrico Moro; David Fredman; Pavla Navratilova; Øyvind Drivenes; Pär G Engström; M Eva Alonso; Elisa de la Calle Mustienes; José Luis Gómez Skarmeta; Maria J Tavares; Fernando Casares; Miguel Manzanares; Veronica van Heyningen; Anders Molven; Pål R Njølstad; Francesco Argenton; Boris Lenhard; Thomas S Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

3.  IRF4 is a key thermogenic transcriptional partner of PGC-1α.

Authors:  Xingxing Kong; Alexander Banks; Tiemin Liu; Lawrence Kazak; Rajesh R Rao; Paul Cohen; Xun Wang; Songtao Yu; James C Lo; Yu-Hua Tseng; Aaron M Cypess; Ruidan Xue; Sandra Kleiner; Sona Kang; Bruce M Spiegelman; Evan D Rosen
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

4.  Cold-activated brown adipose tissue in healthy men.

Authors:  Wouter D van Marken Lichtenbelt; Joost W Vanhommerig; Nanda M Smulders; Jamie M A F L Drossaerts; Gerrit J Kemerink; Nicole D Bouvy; Patrick Schrauwen; G J Jaap Teule
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

5.  Identification and importance of brown adipose tissue in adult humans.

Authors:  Aaron M Cypess; Sanaz Lehman; Gethin Williams; Ilan Tal; Dean Rodman; Allison B Goldfine; Frank C Kuo; Edwin L Palmer; Yu-Hua Tseng; Alessandro Doria; Gerald M Kolodny; C Ronald Kahn
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

6.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.

Authors:  Danielle Welter; Jacqueline MacArthur; Joannella Morales; Tony Burdett; Peggy Hall; Heather Junkins; Alan Klemm; Paul Flicek; Teri Manolio; Lucia Hindorff; Helen Parkinson
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

7.  Genetic variation at the FTO locus influences RBL2 gene expression.

Authors:  Jeremy B M Jowett; Joanne E Curran; Matthew P Johnson; Melanie A Carless; Harald H H Göring; Thomas D Dyer; Shelley A Cole; Anthony G Comuzzie; Jean W MacCluer; Eric K Moses; John Blangero
Journal:  Diabetes       Date:  2009-12-15       Impact factor: 9.461

8.  Variation in FTO contributes to childhood obesity and severe adult obesity.

Authors:  Christian Dina; David Meyre; Sophie Gallina; Emmanuelle Durand; Antje Körner; Peter Jacobson; Lena M S Carlsson; Wieland Kiess; Vincent Vatin; Cecile Lecoeur; Jérome Delplanque; Emmanuel Vaillant; François Pattou; Juan Ruiz; Jacques Weill; Claire Levy-Marchal; Fritz Horber; Natascha Potoczna; Serge Hercberg; Catherine Le Stunff; Pierre Bougnères; Peter Kovacs; Michel Marre; Beverley Balkau; Stéphane Cauchi; Jean-Claude Chèvre; Philippe Froguel
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

Review 9.  The bigger picture of FTO: the first GWAS-identified obesity gene.

Authors:  Ruth J F Loos; Giles S H Yeo
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

10.  Integrative analysis of 111 reference human epigenomes.

Authors:  Anshul Kundaje; Wouter Meuleman; Jason Ernst; Misha Bilenky; Angela Yen; Alireza Heravi-Moussavi; Pouya Kheradpour; Zhizhuo Zhang; Jianrong Wang; Michael J Ziller; Viren Amin; John W Whitaker; Matthew D Schultz; Lucas D Ward; Abhishek Sarkar; Gerald Quon; Richard S Sandstrom; Matthew L Eaton; Yi-Chieh Wu; Andreas R Pfenning; Xinchen Wang; Melina Claussnitzer; Yaping Liu; Cristian Coarfa; R Alan Harris; Noam Shoresh; Charles B Epstein; Elizabeta Gjoneska; Danny Leung; Wei Xie; R David Hawkins; Ryan Lister; Chibo Hong; Philippe Gascard; Andrew J Mungall; Richard Moore; Eric Chuah; Angela Tam; Theresa K Canfield; R Scott Hansen; Rajinder Kaul; Peter J Sabo; Mukul S Bansal; Annaick Carles; Jesse R Dixon; Kai-How Farh; Soheil Feizi; Rosa Karlic; Ah-Ram Kim; Ashwinikumar Kulkarni; Daofeng Li; Rebecca Lowdon; GiNell Elliott; Tim R Mercer; Shane J Neph; Vitor Onuchic; Paz Polak; Nisha Rajagopal; Pradipta Ray; Richard C Sallari; Kyle T Siebenthall; Nicholas A Sinnott-Armstrong; Michael Stevens; Robert E Thurman; Jie Wu; Bo Zhang; Xin Zhou; Arthur E Beaudet; Laurie A Boyer; Philip L De Jager; Peggy J Farnham; Susan J Fisher; David Haussler; Steven J M Jones; Wei Li; Marco A Marra; Michael T McManus; Shamil Sunyaev; James A Thomson; Thea D Tlsty; Li-Huei Tsai; Wei Wang; Robert A Waterland; Michael Q Zhang; Lisa H Chadwick; Bradley E Bernstein; Joseph F Costello; Joseph R Ecker; Martin Hirst; Alexander Meissner; Aleksandar Milosavljevic; Bing Ren; John A Stamatoyannopoulos; Ting Wang; Manolis Kellis
Journal:  Nature       Date:  2015-02-19       Impact factor: 69.504

View more
  518 in total

1.  Scrutinizing the FTO locus: compelling evidence for a complex, long-range regulatory context.

Authors:  Mathias Rask-Andersen; Markus Sällman Almén; Helgi B Schiöth
Journal:  Hum Genet       Date:  2015-09-04       Impact factor: 4.132

2.  Obesity: Beige adipocytes-will they beat obesity?

Authors:  Camilla H Sandholt; Oluf Pedersen
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

3.  COPD diagnosis: genome first.

Authors:  Lawrence Grouse
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 4.  CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.

Authors:  María José Franco-Tormo; Mireille Salas-Crisostomo; Nuno Barbosa Rocha; Henning Budde; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  J Mol Neurosci       Date:  2018-05-07       Impact factor: 3.444

5.  An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility.

Authors:  Samuel Lessard; Emily Stern Gatof; Mélissa Beaudoin; Patrick G Schupp; Falak Sher; Adnan Ali; Sukhpal Prehar; Ryo Kurita; Yukio Nakamura; Esther Baena; Jonathan Ledoux; Delvac Oceandy; Daniel E Bauer; Guillaume Lettre
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 6.  Drug development in the era of precision medicine.

Authors:  Sarah A Dugger; Adam Platt; David B Goldstein
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

7.  Trans Effects on Gene Expression Can Drive Omnigenic Inheritance.

Authors:  Xuanyao Liu; Yang I Li; Jonathan K Pritchard
Journal:  Cell       Date:  2019-05-02       Impact factor: 41.582

8.  Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.

Authors: 
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

Review 9.  Turning omics data into therapeutic insights.

Authors:  Amanda Kedaigle; Ernest Fraenkel
Journal:  Curr Opin Pharmacol       Date:  2018-08-24       Impact factor: 5.547

10.  Genetic mapping of etiologic brain cell types for obesity.

Authors:  Pascal N Timshel; Jonatan J Thompson; Tune H Pers
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.